|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Zyprexa (olanzapine) Tablets, 2.5, 5, 7.5, 10, 15 & 20 mg, Eli Lilly & Co. NDA 20-592/S18 7/10/03 7/28/03 7/10/03 Zyprexa Indications: Short-term treatment of acute manic episodes associated with Bipolar I Disorder, either as monotherapy (S-006) or in combination with lithium or valproate (S-018). Zyprexa (olanzapine) Tablets, Eli Lilly & Co. NDA 20-592/SE1-011 11/9/00 Zyprexa Zydis (olanzapine orally disintegrating) Tablets, Eli Lilly & Co. NDA 21-086 Symbyax (Olanzapine & Fluoxetine HCl) Capsules, Eli Lilly & Co., Inc. Zyprexa (olanzapine) Tablets, Eli Lilly & Co. Zyprexa IntraMuscular (olanzapine) Injection, Eli Lilly & Co. | Symbyax (olanzapine and fluoxetine HCl) Capsules, Eli Lilly and Co., Labeling Revision | Olanzapine Tablets, TEVA Pharma, Tentative Approval | Olanzapine Tablets, Mylan Pharma, Tentative Approval | Zyprexa (olanzapine) tablets, Eli Lilly and Co., Labeling Revision | Zyprexa (olanzapine) Tablets, Eli Lilly and Co., Labeling Revision | Zyprexa Zydis (olanzapine) orally disintegrating tablets, Eli Lilly and Co., Labeling Revision | Zyprexa IntraMuscular (olanzapine for injection), Eli Lilly and Co., Labeling Revision | Olanzapine Tablets, Sandoz Inc., Tentative Approval | Zyprexa (olanzapine) tablets, Eli Lilly and Co., Labeling Revision | Zyprexa Zydis (olanzapine) orally disintegrating tablets, Eli Lilly and Co., Labeling Revision | Zyprexa IntraMuscular (olanzapine) injection, Eli Lilly and Co., Labeling Revision | Symbyax (olanzapine and fluoxetine HCl) capsules, Eli Lilly & Co., Labeling Revision | Zyprexa Tablet, Lilly, Labeling Revision | Zyprexa Injection, Lilly, Labeling Revision | Zyprexa Zydis Tablet, Lilly, Labeling Revision | Symbyax (olanzapine/fluoxetine) capsules, Eli Lilly, Labeling Revision | Olanzapine Tablets, Roxane Labs, Tentative Approval | Olanzapine Orally Disintegrating Tablets, Barr Labs, Tentative Approval | Symbyax (olanzapine and fluoxetine HCl) capsules, Eli Lilly, Labeling Revision | Zyprexa (olanzapine) Tablets, Eli Lilly, Labeling Revision | Zyprexa Zydis (olanzapine) orally disintegrating tablets, Eli Lilly, Labeling RevisionZyprexa IntraMuscular (olanzapine) injection, Eli Lilly, Labeling Revision
|